RxDoctor Payments Data

James Boyland

Optometrist · Wilmington, DENPI 1013977230

Payments from drug & device makers

$617in general payments, 2019–2025

Across 29 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$245
  • Alcon$178
  • Shire North American Group Inc$66
  • Oyster Point Pharma, Inc.$51
  • Johnson & Johnson Vision Care, Inc.$27
  • Bausch & Lomb Americas Inc.$23
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$617100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$617 in reported general payments places this provider in the 40th percentile of 146 optometrist providers in Delaware.

See all optometrist providers in Delaware

Medicare billing

Part B allowed, 2024
$17,681
Medicare patients
144
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha24$258

Paid to pharmacies, not to this prescriber.

Other optometrist in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →